J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahmed, R.
Right arrow Articles by Thorstensson, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmed, R.
Right arrow Articles by Thorstensson, R.
Agricola
Right arrow Articles by Ahmed, R.
Right arrow Articles by Thorstensson, R.

Journal of General Virology, Vol 80, 1569-1574, Copyright © 1999 by Society for General Microbiology


ARTICLES

Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge

RKS Ahmed, C Nilsson, Y Wang, T Lehner, G Biberfeld and R Thorstensson
Swedish Institute for Infectious Disease Control and Microbiology and Tumorbiology Centre, Karolinska Institute, S-171 82 Solna, Sweden

Simian immunodeficiency virus (SIV) uses the CCR5 chemokine receptor as the main co-receptor to enter CD4(+) cells. RANTES, MIP-1alpha and MIP-1beta have been suggested as the major human immunodeficiency virus-suppressor factors produced by CD8(+) T-cells. The aim of this study was to investigate the CD8(+) T-cell production of anti-viral factors and of beta-chemokines in six cynomolgus macaques vaccinated with live attenuated SIVmacC8 in relation to protection against infectious intrarectal SIVsm challenge. Three of the vaccinated animals were completely protected and one was partially protected against the challenge virus. Interestingly, these monkeys showed higher in vitro anti-viral CD8(+) cell suppressor activity and beta-chemokine production both before and after vaccination as compared to the infected monkeys. The results indicate that beta-chemokines may play a role in protective immunity but also that genetic and/or environmental factors may influence their production.


This article has been cited by other articles:


Home page
Adv. Dent. Res.Home page
L.A. Bergmeier and T. Lehner
Innate and Adaptive Mucosal Immunity in Protection against HIV Infection
Adv. Dent. Res., April 1, 2006; 19(1): 21 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Wang, K. Abel, K. Lantz, A. M. Krieg, M. B. McChesney, and C. J. Miller
The Toll-Like Receptor 7 (TLR7) Agonist, Imiquimod, and the TLR9 Agonist, CpG ODN, Induce Antiviral Cytokines and Chemokines but Do Not Prevent Vaginal Transmission of Simian Immunodeficiency Virus When Applied Intravaginally to Rhesus Macaques
J. Virol., November 15, 2005; 79(22): 14355 - 14370.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
P. t. Haaft, E. J. Verschoor, B. Verstrepen, H. Niphuis, R. Dubbes, W. Koornstra, W. Bogers, B. Rosenwirth, and J. L. Heeney
Readily acquired secondary infections of human and simian immunodeficiency viruses following single intravenous exposure in non-human primates
J. Gen. Virol., December 1, 2004; 85(12): 3735 - 3745.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
L. Sun, S. F. Abdelwahab, G. K. Lewis, and A. Garzino-Demo
Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization
Int. Immunol., November 1, 2004; 16(11): 1623 - 1631.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. LaFranco-Scheuch, K. Abel, N. Makori, K. Rothaeusler, and C. J. Miller
High Beta-Chemokine Expression Levels in Lymphoid Tissues of Simian/Human Immunodeficiency Virus 89.6-Vaccinated Rhesus Macaques Are Associated with Uncontrolled Replication of Simian Immunodeficiency Virus Challenge Inoculum
J. Virol., June 15, 2004; 78(12): 6399 - 6408.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Abel, L. Compton, T. Rourke, D. Montefiori, D. Lu, K. Rothaeusler, L. Fritts, K. Bost, and C. J. Miller
Simian-Human Immunodeficiency Virus SHIV89.6-Induced Protection against Intravaginal Challenge with Pathogenic SIVmac239 Is Independent of the Route of Immunization and Is Associated with a Combination of Cytotoxic T-Lymphocyte and Alpha Interferon Responses
J. Virol., March 1, 2003; 77(5): 3099 - 3118.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. L. Shacklett, K. E. S. Shaw, L. A. Adamson, D. T. Wilkens, C. A. Cox, D. C. Montefiori, M. B. Gardner, P. Sonigo, and P. A. Luciw
Live, Attenuated Simian Immunodeficiency Virus SIVmac-M4, with Point Mutations in the Env Transmembrane Protein Intracytoplasmic Domain, Provides Partial Protection from Mucosal Challenge with Pathogenic SIVmac251
J. Virol., October 11, 2002; 76(22): 11365 - 11378.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
U. F. Power, T. Huss, V. Michaud, H. Plotnicky-Gilquin, J.-Y. Bonnefoy, and T. N. Nguyen
Differential Histopathology and Chemokine Gene Expression in Lung Tissues following Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV- or BBG2Na-Immunized Mice
J. Virol., December 15, 2001; 75(24): 12421 - 12430.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Kamin-Lewis, S. F. Abdelwahab, C. Trang, A. Baker, A. L. DeVico, R. C. Gallo, and G. K. Lewis
Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta
PNAS, July 19, 2001; (2001) 161298998.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
L. Walther-Jallow, C. Nilsson, J. Soderlund, P. ten Haaft, B. Makitalo, P. Biberfeld, P. Bottiger, J. Heeney, G. Biberfeld, and R. Thorstensson
Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys
J. Gen. Virol., July 1, 2001; 82(7): 1601 - 1612.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S.-W. Wang, P. A. Kozlowski, G. Schmelz, K. Manson, M. S. Wyand, R. Glickman, D. Montefiori, J. D. Lifson, R. P. Johnson, M. R. Neutra, et al.
Effective Induction of Simian Immunodeficiency Virus-Specific Systemic and Mucosal Immune Responses in Primates by Vaccination with Proviral DNA Producing Intact but Noninfectious Virions
J. Virol., November 15, 2000; 74(22): 10514 - 10522.
[Abstract] [Full Text]


Home page
JEMHome page
K. J. Metzner, X. Jin, F. V. Lee, A. Gettie, D. E. Bauer, M. Di Mascio, A. S. Perelson, P. A. Marx, D. D. Ho, L. G. Kostrikis, et al.
Effects of In Vivo CD8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine
J. Exp. Med., June 6, 1999; 191(11): 1921 - 1932.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Kamin-Lewis, S. F. Abdelwahab, C. Trang, A. Baker, A. L. DeVico, R. C. Gallo, and G. K. Lewis
Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta
PNAS, July 31, 2001; 98(16): 9283 - 9288.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1999 by the Society for General Microbiology.